Development of CYP8B1-specific inhibitors for metabolic diseases
Zhipeng Fang, Alon Roy L. Agua, Jennifer Jossart, Nisha Sharma, Xintian Lyu, Zhe Wang, Shili Zhang, Ji Sun, Linsen Shi, Juan Ayard, Maggie Chang, Jiahui Liu, Kevin Kou, John Shively, Adolfo Garcı́a-Ocaña, , Wendong Huang
This study develops CYP8B1-specific inhibitors that alter bile acid composition, remodel gut microbiota, and improve metabolic disease in a mouse model.
bioRxiv · Oct 22, 2026 · PreprintPharmacology & Toxicology